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RESULTS OF AN 
AUTOLOGOUS TISSUE 
RECONSTRUCTION FOR 
REPLACEMENT OF 
OBSTRUCTED 
EXTRACARDIAC CONDUITS 
Between May 1983 and March 1, 1995, 50 patients had replacement of an 
obstructed pulmonary ventricle-pulmonary artery conduit with an autolo- 
gous tissue reconstruction i which a prosthetic roof was placed over the 
fibrous tissue bed of the explanted conduit. The roof was constructed with 
xenograft pericardium (most recently) (n = 42), homograft dura mater 
(n = 5), or Dacron fabric (n = 3). Patient ages ranged from 5 to 34 years 
(median 16 years). The explanted conduits were Hancock conduits (n = 33), 
Tascon conduits (n = 6), homograft (n = 4), Dacron tube (n = 3), and 
others (n = 4). Preoperative maximum systolic gradients ranged from 44 to 
144 mm Hg (median 78 mm Hg). Thirty-seven concomitant cardiac 
procedures were done in 29 patients. When a valve was necessary (n = 15), 
it was possible to place a large-sized valve in the autologous tissue 
reconstructions (range 22 to 29 mm, median 26 mm). Cardiopulmonary 
bypass times ranged from 34 to 223 minutes (median 84 minutes), and 
aortic crossclamp times ranged from 0 (in 32 patients) to 109 minutes 
(median 0 minutes). Intraoperative postrepair peak systolic gradients from 
pulmonary ventricle to pulmonary artery ranged from 0 to 33 mm Hg 
(median 13 mm Hg). There was one arly death (2%) in a patient who had 
additional cardiac procedures. Follow-up was complete in all patients and 
ranged from 1 month to 11.8 years (median 7.5 years). There were two 
sudden late deaths: conduits in both were known to be free from obstruc- 
tion. F0rty-four of the 47 surviving patients had evaluation of the gradient 
by echocardiography or cardiac catheterization 1 month to 1i years 
(median 7 years) after operation. The gradients ranged from 5 to 45 mm Hg 
(median 20 mm Hg). None of the conduits developed an obstructive peel, 
valve obstruction, or valve incompetence. At 10 years, the freedom from 
reoperation for conduit obstruction was 100%, and freedom from reoperation 
for any cause was 81%. This technique simplifies conduit replacement, allows 
for a generous-sized outflow tract, has a low risk, and yields late results that 
appear superior to those of cryopreserved homografts or other types of 
extracardiac conduits. (J THORAC CARDIOVASC SURG 1995;110:1359-68) 
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T he idea~ extracardiac onduit should be easily implanted, lack degeneration or the development 
of obstruction, allow for growth, be free from insuf- 
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ficiency, and not necessitate the use of anticoagu- 
lants. As is the case with cardiac valves, the ideal 
conduit has not yet been developed. Children who 
undergo pulmonary ventricle-pulmonary artery 
(PV-PA) connections with prosthetic materials may 
require multiple reoperations because of conduit 
failure. (We use the term pulmonary ventricle rather 
than right ventricle because one patient had cor- 
rected transposition in which the pulmonary ventri- 
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Fig. 1. Technique of autologous tissue reconstruction for replacement of obstructed cardiac conduit. 
Upper panel shows obstructed Dacron conduit being removed from thick fibrous peel that surrounds it 
(solid alTow). Lowerpanel i lustrates pericardial roof being sewn to lateral (lat.) edges of fibrous tissue bed. 
Pul., Pulmonary; Ao, aorta; SVC, superior vena cava; RV, right ventricle. (From Danielson GK, Downing 
TP, Schaff HV, Puga FJ, DiDonato RM, Ritter DG. (J THORAC CARD1OVASC SURG 1987;93:555-9.) 
cle was the morphologically eft ventricle.) We have 
previously reported a new procedure that replaces 
an obstructed extracardiac onduit with an autolo- 
gous tissue reconstruction in which a pericardial 
roof is placed over the fibrous tissue bed of the 
explanted conduit (Fig. 1). 1 The follow-up of these 
16 patients and our experience with 34 other pa- 
tients undergoing a similar procedure are presented. 
Patients and methods 
Between May 1983 and March 1, 1995, 50 patients with 
obstructed PV-PA conduits underwent an autologous 
tissue reconstruction in which a prosthetic roof was placed 
over the fibrous tissue bed of the explanted conduit. There 
were 31 male and 19 female patients with an age range of 
5 to 34 years (median 16 years). The conduits in place 
before the autologous tissue reconstructions were stan- 
dard Hancock 100 orifices* (n = 19), Hancock modified 
150 orifices (n = 14), Tascon conduits* (n = 6), ho- 
mografts (n = 4), Dacron tubes (n = 3), Ionescu-Shiley 
conduitst (n = 2), and Carpentier-Edwards conduits$ 
(n = 2). The sizes of the conduits in place before the 
reconstructions ranged from 8 to 26 mm (median 22 ram); 
46 were valved and 4 were nonvalved (Dacron tube, n = 
3; Tascon tube, n = 1). More than one previous conduit 
had been placed in 10 patients: 9 patients had received 
two and 1 patient had received four previous conduits. 
Cardiac diagnoses were transposition of the great arteries 
*Medtronic Heart Valves, Irvine, Calif. 
?Shiley, Inc., Irvine, Calif. 
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(n = 18), pulmonary atresia (n = 14), truncus arteriosus 
(n = 8), double-outlet right ventricle (n = 5), tetralogy of 
FalIot (n = 4), and corrected transposition ( = 1). In 41 
patients (82%) the conduit coursed to the left of the aorta 
and in 9 patients it coursed to the right of the aorta. The 
time between the prior conduit operation and the autol- 
ogous tissue reconstruction ranged from 1.2 to 20 years 
(median 8years), and the primary indication for operation 
was severe conduit obstruction in all patients. Preopera- 
tive systolic gradients measured by cardiac atheterization 
(peak-to-peak gradients) or echocardiography (maximum 
instantaneous gradients) ranged from 44 to 144 mm Hg 
(median 78 mm Hg). 
The obstructed conduit was exposed via a repeat me- 
dian sternotomy, which was done with special care be- 
cause the conduit and valve ring or calcified homograft 
was often adherent to the sternum or had eroded into it. 
An attempt was made to perform resternotomy and 
central cannulation whenever possible, but femoral artery 
and vein cannulations were required in some patients to 
establish cardiopulmonary b pass before or during rester- 
notomy. After resternotomy, the heart was exposed suffi- 
ciently to allow central cannulation, and the conduit was 
initially identified but not dissected free. Cardiac cham- 
ber, conduit, and distal pulmonary artery pressures were 
measured when feasible. Single right atrial or double caval 
cannulation was done, depending on the operative com- 
plexity and the necessity of performing associated intra- 
cardiac procedures. 
In some patients who did not require associated intra- 
cardiac procedures and in whom there were no residual 
intracardiac shunts, the perfusate temperature was low- 
ered to 32 ° C to 34 ° C, an aortic tack vent was placed, the 
heart was kept beating, and the conduit was replaced 
without crossclamping the aorta. In the other patients, 
moderate hypothermia (20 ° to 28 ° C), aortic crossclamp- 
ing, and myocardial protection with cold blood potassium 
cardioplegic solution were used. Exposure for the distal 
anastomosis was often facilitated with short periods of low 
flow (0.5 L/rain per square meter). 
A longitudinal incision was made anteriorly over the 
course of the obstructed conduit, and the conduit was 
dissected free from the external fibrous peel and excised. 
The sides and floor of the conduit bed were preserved. 
Distal suture-line stenoses were relieved and the right and 
left pulmonary arteries were measured with probes. If 
they were of normal size or greater and if the preoperative 
or prebypass distal pulmonary arterial pressure was nor- 
mal, no valve was used in the reconstruction i many of 
the patients, especially early in our experience. If the 
pulmonary arteries were relatively hypoplastic or if pul- 
monary hypertension was present, a tissue or mechanical 
valve was always used. The right ventricular outflow tract 
was examined and any muscular outlet obstruction was 
resected. Any necessary intracardiac procedures were 
then done. 
When it became available, glutaraldehyde-preserved 
bovine pericardium was favored for construction of the 
roof of the new conduit. The suture line was begun distally 
and the shape of the patch was altered as necessary to 
provide relief of proximal right or left pulmonary artery 
stenoses. In some patients, a T-shaped reconstruction of
the right and left pulmonary arteries was made with the 
pericardial patch before it was brought proximally and 
sewn to the edges of the conduit bed. The suture line was 
restricted to the fibrous tissue at the edge of the conduit 
bed to avoid injury to any adjacent, obscured coronary 
arteries. Before completion of the proximal anastomosis, 
the newly created PV-PA conduit was sized with dilators. 
When a valve was required, it was placed so as to minimize 
compression by the sternum, usually by positioning it as 
close to the distal anastomosis as possible. However, for 
patients with pulmonary atresia, it was often possible to 
place the valve at or just proximal to the level of the 
pulmonary anulus. The valve was secured with mattress 
sutures passed through felt pledgets posteriorly and later- 
ally in the conduit bed. Anteriorly, the sewing ring was 
attached to the pericardial roof patch with a running 
monofilament suture; this was facilitated by temporarily 
reflecting the proximal portion of the pericardial patch 
distally and suturing the resultant pericardial fold to the 
sewing ring. The proximal pericardial patch was then 
reflected proximally and sewn to the right ventricular 
outflow tract to complete the reconstruction. 
For those cases in which the heart was kept perfused 
and beating, removal of the distal conduit and prepara- 
tions for the distal anastomosis were facilitated by clamp- 
ing the conduit as far proximally as possible and then 
dividing the conduit distal to the clamp. After the distal 
reconstruction was completed and the patch was sutured 
anteriorly to the level of the clamp, the clamp was 
removed, the proximal conduit remnant was excised, and 
the proximal pericardial patch was closed to the pulmo- 
nary ventricular outflow tract. 
When the patient was weaned from cardioputmonary 
bypass, pressures were measured in the pulmonary ven- 
tricle and distal pulmonary artery. The lobe of the thymus 
on the side of the conduit was removed, together with 
fibrous tissue in the mediastinum and on the chest wall in 
the region of the reconstruction, to allow maximal room 
for the conduit. Resection of overlying sternal bone and 
costal cartilage was done as necessary to prevent compres- 
sion of the reconstruction. 
The quality of the fibrous tissue bed of the explanted 
conduit varied widely according to the type of conduit. 
The conduit could be removed most easily when it was 
made of tightly woven Dacron fabric (for example, the 
Hancock conduit), and the remaining fibrous tissue bed 
was of good quality. The Tascon conduit was more firmly 
embedded in the surrounding fibrous tissue, necessitating 
a careful dissection to free it from the fibrous bed. 
Calcified homografts were often managed by removing 
the calcium with an endarterectomy technique, leaving the 
adventitia of the homograft and adjacent fibrous tissue as 
the floor of the new reconstruction. I  one of our patients, 
a satisfactory fibrous floor was not present after excision 
of the conduit. In this case, a generous-sized pericardial 
tube was formed with an anterior suture line. A 25 mm 
porcine valve was also placed in this conduit. 
It is important o know the location of any coronary 
arteries that course posterior to the conduit to avoid 
injury to them during removal of the obstructed conduit 
and when a valve is placed in the new reconstruction. The 
left coronary artery is most often at risk. The artery can 
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Table I. Concomitant cardiovascular p ocedures 
Procedure No. of patients 
Closure of residual ventricular septaI defect 10 
Pulmonary angioplasty 9 
Tricuspid annuloplasty 6 
Closure of residual trial septal defect 4 
Aortic valve- replacement 4 
Aortic patch enlargement 2 
Closure of left ventricle-pulmonary artery fistula 1 
Tricuspid valve replacement 1 
either be compressed by an inappropriately placed valve 
or it can be distorted or obstructed by sutures used to 
attach the new conduit valve. 
Follow-up was achieved by obtaining the records of the 
most recent examination at our institution, letters from 
home physicians, and copies of the most recent outside 
echocardiograms and cardiac atheterization reports. Pa- 
tients were asked by telephone interview or questionnaire 
to grade their health status as excellent, good, fair, or 
poor. The patient's exercise tolerance was assessed by 
asking them if they were able to do as much as their peers, 
half as much, one quarter as much, or less than one 
quarter as much. Employment and educational statuses 
were determined. The reproductive status of the female 
patients was assessed. 
Early mortality was defined as any death that occurred 
before hospital discharge or within 30 days of operation. 
Survival was estimated by the Kaplan-Meier method with 
the date of the autologous tissue reconstruction used as 
the starting point. The influence of variables on survival 
was analyzed by the log-rank test for discrete variables and 
the proportional hazards Cox model for continuous vari- 
ables. Values of p < 0.05 were considered statistically 
significant. 
Results 
Early results. Thirty patients underwent heir 
second median sternotomy, 17 their third, 2 their 
fourth, and 1 their fifth. Cannulation was done via 
the aorta and right atrium in 31 patients, via the 
femoral artery and right atrium in 8 patients, and via 
both the femoral artery and vein in 11 patients. The 
right ventricle was entered uring resternotomy in 1 
patient. It was recognized before operation that the 
conduit in this patient had eroded into the posterior 
table of the sternum, so the femoral vessels were 
dissected free before the resternotomy was begun. 
Cardiopulmonary b pass was instituted via the fem- 
oral vessel s, resternotomy was completed, the right 
ventricle was repaired, and the conduit reconstruc- 
tion proceeded uneventfully. The patient did not 
require any blood transfusions and had an uncom- 
plicated 7-day hospital course. 
The 50 roof patches were constructed with glut- 
araldehyde-preserved bovine pericardium (n = 42), 
homograft dura mater (n = 5), or Dacron fabric 
(n = 3). Fifteen patients had valves placed in the 
conduit; 13 were porcine valves (Carpentier-Ed- 
wards valve [n = 12] and Tascon valve left in place 
[n = 1]) and 2 were mechanical valves (Starr- 
Edwards* [n = 1] and Bj6rk-Shiley? [n = 1]). Thirty 
of the 42 pericardial roofed conduits, 3 of the 5 dura 
mater roofed conduits, and 2 of the 3 Dacron fabric 
roofed conduits were nonvalved. 
Thirty-seven concomitant cardiovascular proce- 
dures were done in 29 patients as shown in Table I. 
Cardiopulmonary bypass times ranged from 34 to 
223 minutes (median 84 minutes). In 32 patients the 
aorta was not crossclamped. In the remaining 18 
patients the aortic crossclamp time ranged from 10 
to 109 minutes (median 68 minutes). Intraoperative 
postrepair peak systolic onduit gradients measured 
before closure in 25 patients ranged from 4 to 33 
mm Hg (median 13 mm Hg). Partial sternal resec- 
tion with or without concomitant costal cartilage 
resection was done in 5 patients to prevent conduit 
compression. 
There was one early death (2%) in a patient with 
transposition of the great arteries who underwent 
reoperation for conduit obstruction, residual ven- 
tricular septal defect, and right pulmonary artery 
stenosis. The prior conduit had eroded into an 
unrecognized single coronary artery just distal to its 
origin from the aorta. This artery was exposed 
during removal of the conduit and was repaired 
along with the residual ventricular septal defect and 
the right pulmonary artery stenosis. However, the 
patient could not be weaned from cardiopulmonary 
bypass. Nonfatal complications included exploration 
for control of chest wall bleeding (n = 3) and atrial 
arrhythmias (n = 3). Hospital stay in the early 
survivors ranged from 6 to 23 days (median 9 days). 
Late results. Follow-up was complete in all pa- 
tients and ranged from 1 month to 11.8 years 
(median 7.5 years). There were two sudden late 
deaths, both in patients who were in New York 
Heart Association functional class I. One patient 
died 4 years after operation while playing a video 
game, and the other died 5 years after operation 
after colliding with another player during a baseball 
game. Both had had recent echocardiograms that 
showed no evidence of conduit obstruction. In 44 of 
the surviving 47 patients, the PV-PA conduits were 
*Baxter Healthcare Corp., Santa Ana, Calif. 
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Fig. 2. Freedom from reoperation because of conduit failure and any cause. 
evaluated by echocardiography (n = 43) or cardiac 
catheterization (  = 1) i month to 11 years (median 
7 years) after operation. The median follow-up for 
the 15 patients with valved conduits was 6 years and 
for the 35 patients with nonvalved conduits was 7 
years. Conduit gradients varied from 5 to 45 mm Hg 
(median 20 mm Hg). 
Five patients required reoperation; all had re- 
ceived nonvalved reconstructions. The median age 
at operation for the patients receiving valved con- 
duits was 19 years (range 11 to 34 years) and the 
median age at operation for the patients receiving 
nonvalved conduits was 15 years (range 5 to 27 
years) (p = not significant). Three patients, aged 19, 
20, and 30 years at the time of receiving a nonvalved 
reconstruction, subsequently underwent placement 
of a valve in the pulmonary position because of 
symptoms of the right side of the heart, right 
ventricular dilatation, and a concern about deterio- 
rating righti ventricular function. These patients had 
undergone two, two, and three cardiac operations 
before the inonvalved reconstructions, respectively. 
One of the three, in whom pulmonary hypertension, 
right pulmonary artery stenosis, and tricuspid insuf- 
ficiency had developed, underwent insertion of a 
cryopreserved aortic homograft, enlargement of the 
right pulmdnary artery, and a tricuspid annuloplasty. 
Five years later the homograft, which had become 
calcified and obstructed, was resected and a valved 
autologous:tissue reconstruction was done. A sec- 
ond patient, in whom atrial and ventricular arrhyth- 
mias had developed, underwent insertion of a cryo- 
preserved pulmonary homograft and a pacemaker 
cardioverter-defibrillator. Thethird patient received 
a cryopreserved pulmonary homograft; two years 
later, reoperation was necessitated by homograft 
obstruction, and a new pulmonary homograft was 
placed. 
Conduit failure was defined as need for reopera- 
tion because of conduit stenosis or extrinsic com- 
pression, conduit valve insufficiency, or anastomotic 
dehiscence or aneurysm. Freedom from reoperation 
for conduit failure was 100% (Fig. 2). Freedom from 
reoperation for any cause was 92% at 5 years and 
81% at 10 years (Fig. 2). Freedom from reoperation 
for any cause for the 35 patients with nonvalved 
conduits was 90% at 5 years and 77% at 10 years 
(Fig. 3). Freedom from reoperation for any cause 
for the 15 patients with valved conduits was 100% at 
both 5 and 10 years (p = 0.30). 
Of the 47 late survivors, 40 (85%) rated their 
health status as excellent and 7 (15%) rated it as 
good. Four patients had one or more episodes of 
tachyarrhythmia and one reported dull chest pain; 
the remaining 42 patients were free of symptoms. 
Forty-three patients aid that they could do as much 
as their peers and 4 patients said they could do 
about half as much. Fourteen of the 15 patients 
(93%) currently in school are able to take courses 
full time and 17 of the 19 patients (89%) employed 
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Fig. 3. Freedom from reoperation because of any cause for valved and nonvalved conduits. 
outside the home work 40 hours or more per week. 
One patient has had an uneventful pregnancy and 
delivery of a normal, healthy child. 
Discussion 
The development of the extracardiac conduit has 
been one of the greatest advances incardiac surgery. 
Conduits have decreased the mortality of several 
standard operations and have made possible correc- 
tion of numerous complex congenital cardiac anom- 
alies that previously were uncorrectable. However, 
as is the case with cardiac valves, the ideal conduit 
has not yet been developed. Our first extended 
experience with conduits used the irradiated aortic 
homograft.2. 3 The wall of this homograft calcified, 
often within 1 year, and the valve subsequently 
calcified and degenerated, resulting in both conduit 
stenosis and insufficiency. The next conduit we used 
(in 1972) was the Hancock conduit, a commercially 
available Dacron tube containing a glutaraldehyde- 
preserved porcine valve. This conduit had the ad- 
vantage of ready availability in many sizes, and it was 
longer and more versatile in the repair of various 
pulmonary artery anomalies. The Hancock conduits 
lasted longer than the irradiated homografts (Fig. 
4), but the porcine valve also calcified with time and 
became both stenotic and insufficient. In addition, 
these conduits developed obstructive peels, 4'5 a 
complication ot seen in the homografts. Another 
unanticipated complication was dissection behind 
the peel caused by incomplete neointimal healing in 
the conduit. 4'5 Major stenoses in the Hancock con- 
duits occurred at the valve alone in approximately 
one third, because of intimal peel in the graft in one 
third, and in both the valve and the graft in one 
third. 4 In our experience, more recently available 
Dacron conduits with porcine oi pericardial valves 
(Tascon, Carpentier-Edwards, Ionescu-Shiley con- 
duits) have not shown any long-term advantages 
compared with the Hancock conduit. 
Attempts at our institution to reduce the preva- 
lence of late conduit failure have included the use of 
nonvalved tube grafts wheri the pulmonary artery 
pressure is expected to be low. s This concept is 
based on the observation that the vast majority of 
patients having repair of tetralogy of Fallot with 
residual pulmonary insufficiency have done well 
without he need for pulmonary valve placement in
a follow-up of 29 to 34 years] This observation 
combined with the knowledge that porcine valves 
contributed to major stenoses in two thirds of 
obstructed Hancock conduits influenced us to use a 
nonvalved autologous tissue reconstruction i  suit- 
able patients. The pulmonary insufficiency was tol- 
erated well in most of the patients, but was associ- 
ated with late development of right ventricular 
enlargement and reduced right ventricular ejection 
fraction in three patients, one of whom also had 
tricuspid insufficiency. When this occurred, reopera- 
tion was offered for placement of a pulmonary valve 
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Fig. 4. Freedom from reoperation because of conduit failure for autologous tissue reconstruction, 
irradiated aortic homograft, cryopreserved aortic homograft, and Hancock conduits. 
and correction of the tricuspid insufficiency with an 
annuloplastY. These three patients had no charac- 
teristics that, in retrospect , would have predicted th e 
eventual need for a valve. However, they were older 
than the median age of patients receiving a non- 
valved reconstruction, and all had two or more 
cardiac oplerations before the reconstruction. The 
large porc!ne valves that could be implanted in this 
series have remained failure-free to date, and eval- 
uation of a !arg er (n = 359) and earlier Series of 
porcine-valved Dacron PV-PA conduits has shown 
that survival free of reoperation is best for the 
largest sizes (unpublished data). Accordingly , in our 
more recent experience, we have been more liberal 
in our use; of porcine bioprostheses in the autolo- 
gous tissue reconstructions. 
We have also had an extensive xperience with 
cryopreserved aortic and pulmonary homografts, 
which were initially used in an effort to reduce the 
prevalenceiof late conduit failure. 8The follow-up of 
our series'of cryopreserved aomc (n = 230) and 
pulmonary (n = 118) homografts extends to 8.8 
years with ~ mean of 2.7 years for aortic homografts 
and 3.2 years for pulmonary homografts. 8 The ho- 
mograft seyies included both primary implantations 
and replacements of previous PV-PA conduits. The 
median ag~ of the patients was less than that of 
• • i • . pat]ents ]r~ the reconstruction series (9 years for 
aortic honlograft recipients and 12 years for pulmo- 
nary homograft recipients versus 16 years for pa- 
tients in the autologous tissue reconstruction series), 
and none of the patients in the reconstruction series 
were 4 years old or less. Nevertheless, freedom from 
reoperation for crYopreserved aortic homograft fail- 
ure was only 70% at 5 years, which is similar to the 
72% freedom from reoperation for our earlier series 
of irradiated homografts (n = 131, unpublished 
data) (Fig. 4). The cryopreserved pulmonary ho- 
mografts fared better when graft failure was defined 
as conduit stenosis and insufficiency only , but when 
anastomotic false aneurysm was included in the 
definition, the 5-year freedom from reoperation for 
conduit failure was not significantly different from 
that of the cryopreserved aortic homografts. 
The autologous tissue reconstruction has several 
potential advantages. First, by retaining the poste- 
rior and lateral portions of the explanted conduit 
fibrous bed, it maintains a surface of autologous 
tissue that does not form a progressive obstructive 
peel. In our experience, glutaraldehyde-preserved 
bovine pericardium used for the roof of the repair 
and for other reconstructive procedures on the 
pulmonary artery also does not form a progressive 
obstructive peel. Another advantage is that the 
diameter of the PV-PA conduit can be made as 
large as desired; it was of normal adult size or larger 
in all of the patients in this series. This technique 
also allows a large size of bioprosthesis to be in- 
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serted that decreases the PV-PA gradient and asso- 
ciated turbulence and valve trauma to minimal 
levels, potentially delaying the development of valve 
deterioration and calcification and subsequent need 
for valve replacement. The distal portion of the 
pericardial patch may be tailored to allow easy 
enlargement of the proximal right and left pulmo- 
nary arteries, and in the majority of cases the 
construction can be done without the need for 
crossclamping the aorta. 
Perhaps the most important criterion for evaluat- 
ing the late function of an extracardiac conduit is to 
consider its survivorship free of the need for reop- 
eration for conduit failure. Fig. 4 compares the 
survivorship free of reoperation because of conduit 
failure of the autologous tissue reconstruction with 
our previous results with the Hancock conduit (p = 
0.0004), the irradiated homograft (p < 0.0001), and 
the cryopreserved aortic homograft. The autologous 
tissue reconstruction compares favorably with the 
other types of conduits. Further extensive long-term 
evaluation of this technique seems warranted. 
We gratefully acknowledge the secretarial support of 
Merrilee Rogotzke. 
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Discussion 
Dr. Edward L. Bove (Ann Arbor, Mich.). The procedure 
that we have just heard presented by Dr. Cerfolio from the 
Mayo Clinic group was first reported by them in 1987 and 
offers a simplified technique for the replacement of the 
obstructed PV-PA conduit by using the fibrous tissue bed, 
or conduit peel, of the explanted conduit o serve as the 
posterior wall of the pathway. The remainder of the 
pathway is fashioned by constructing a roof of prosthetic 
material or, as currently preferred by the authors, xe- 
nograft pericardium. The major advantage of the ap- 
proach is to minimize operative dissection, particularly 
over the coronary arteries, which reduces the potential for 
injury and simplifies the procedure. 
It is clear that the ideal conduit, one that will not result 
in obstruction and will provide a competent valve, is not 
available. Dacron conduits with heterograft tissue valves 
will all become obstructed in time as a result of fibrous 
tissue peel formation and leaflet calcification. The resur- 
gence of allografts, either cryopreserved or fresh, has not 
proved to be the panacea that many had hoped. The 
obstructive problems of the latter, however, appear more 
common with the aortic than the pulmonary allografts, 
and data are now emerging to show that the durability of 
larger-size pulmonary allografts is quite excellent, partic- 
ularly when Dacron extensions or hoods are avoided. 
Thus it seems that reoperation because of conduit 
problems with use of the technique described by the Mayo 
Clinic group will be predicated on the status of the valve: 
reoperation will be required because of either obstruction 
in those patients with tissue valves or insufficiency in those 
without valves in whom signs and symptoms of right 
ventricular volume overload may eventually develop. Re- 
operation for late pulmonary valve insertion, however, 
should be uncommonly required, as the long-term fol- 
low-up of those patients with repaired tetralogy of Fallot 
with transannular right ventricular outflow tract patches 
has demonstrated. Therefore, as the Mayo Clinic group 
has already shown, it is important to carefully select hose 
patients who will require a valve at the time of conduit 
replacement to ensure an optimal hemodynamic outcome 
for the longest possible duration. Patients with pulmonary 
artery hypertension because of unrelieved pulmonary 
artery stenoses, hypoplastic branch pulmonary arteries, 
and pulmonary vascular disease and those with left ven- 
tricular dysfunction are at the greatest risk of requiring 
valve insertion. Those with significant right ventricular 
dysfunction or unrepaired tricuspid insufficiency may also 
likely tolerate additional volume overload poorly. 
When a valve is required, a tissue valve inserted in the 
conduit as described by the authors will provide excellent 
function and durability and will be superior to other 
Dacron conduits by avoiding recurrence of fibrous tissue 
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peel formation. Insertion of a cryopreserved pulmonary 
allograft, however, will serve the same purpose, although 
the prevalence of regurgitation will be higher. If a valve is 
likely to be needed only during the early postoperative 
period to convey at least a transient hemodynamic benefit, 
the allograft may be the better option because the devel- 
opment of late valve regurgitation may not necessitate 
reoperation, whereas late tissue valve obstruction as a 
result of leaflet calcification will. Some groups have opted 
for insertion of a monocusp valve in these situations. 
Although the authors describe successful use of two 
mechanical valves in their patients, long2term results even 
with anticoagulation have not been ideal in this group. 
I have three questions for Dr. Cerfolio. What are the 
limitations of this technique and when would the authors 
select an allograft conduit instead? Second, what are the 
indications for use of a mechanical valve? Finally, do the 
authors have any late data on right ventricular function or 
aneurysm formation in these patients? 
Dr. Cerfolio. Dr. Bove's first questions concern the 
limitations of the technique and when would we choose to 
use an allograft. The technique is currently limited to 
replacement of a previous conduit. Tightly woven Dacron 
fabric produces the best fibrous bed for the reconstruc- 
tion, but we have done this operation after explantation of
other types of conduits including polytetrafluoroethylene 
tubes and homografts. 
In a recent study published by Bando and colleagues (J
THORAC CARDIOVASC SURG 1995;109:509-18), we looked 
at late results of cryopreserved pulmonary and aortic 
homografts. Although we did find that pulmonary ho- 
mografts in the right ventricular position fared better than 
aortic homografts, the definition of conduit failure that 
was used did not include aneurysm formation at the 
anastomoses, as it did in this paper. When one includes 
that compl!cation i the definition, freedom from conduit 
failure of the pulmonary homograft was not statistically 
different frOm that of the aortic homograft. In view of the 
aneurysm problem and the increasing prevalence of late 
valve insufficiency in pulmonary homografts, especially 
when pulmonary hypertension is present, we tend to use 
autologous reconstructions for conduit reoperations, ex- 
cept perhaps for patients younger than age 4 years. 
The next question concerned the indication for use of a 
mechanical valve. Mechanical valves are used infre- 
quently. Both patients with mechanical valves in this series 
had pulmonary hypertension and previous bioprosthetic 
valve failures. Both receive anticoagulation a d the valves 
in both are :functioning well 11 and 8 years after operation, 
respectively. 
With regard to the last question, there were no false 
aneurysms in this series of autologous tissue reconstruc- 
tions. Symptoms of the right side of the heart, an enlarg- 
ing right ventricle, and concern about decreasing right 
ventricular ejection fraction were factors that influenced 
the decision for placement of a pulmonary valve in three 
patients who initially had received a nonvalved recon- 
struction. 
Dr. Guillermo O. Kreutzer (Buenos Aires, Argentina). If 
the authors' philosophy is to use autologous tissue, my 
question is this: why not use it from the beginning when no 
pericardia1 adhesions are present? 
Since 1983 we have been using an unpreserved autolo- 
gous pericardial bicuspid valve conduit constructed as 
large as possible with a minimum diameter according to 
the surface area requirements. We reviewed the interme- 
diate and long-term follow-up of all 51 patients with an 
age range from 1 year to 10.4 years (median 5 years). The 
original conduit diameter implanted ranged from 12 to 20 
mm (median 16 mm). 
At follow-up 1 month after operation with two- 
dimensional Doppler echocardiography, there was no 
or trivial conduit valve regurgitation. At the most recent 
follow-up, the median gradient was 21 mm Hg. The 
diameter increased 1 to 7 mm in 27 patients, did not 
change in 20, and only in 4 was there a reduction of 1 to 
2 ram. Six reoperations were done related to gradients. 
Four of these were at the distal anastomosis line and in 
conduits implanted before 1986. At that time we had 
started to complete the distal anastomosis over a Hegar 
bougie and to use polydioxanone sutures in four quad- 
rants. 
The actuarial freedom from reoperation was 90% at 5 
years and 100% for conduits measuring more than 16 mm 
at the time of implantation. After the technical modifica- 
tion in 1986, the actuarial survival and freedom from 
reoperation was 96.6% at 7 years. Long-term follow-up 
compared favorably with that for the cryopreserved ho- 
mograft with a lower prevalence of reoperations. In our 
opinion this conduit is the only one that has the tendency 
to increase its diameter. Furthermore, it is less expensive 
and, in addition, represents a valid option for the Ross 
operation. 
Dr. Cerfolio. We do not have any experience with an 
autologous pericardial bicuspid conduit. However, Dr. 
Kreutzer touched on a couple of points that I think our 
technique also includes. First of all, we do have one 
patient who had a previous pulmonary homograft who 
underwent reoperation because of insufficiency and ob- 
struction, and in that patient we tried to do an endarter- 
ectomy in the calcified part of the homograft. However, 
the floor of the tissue bed was not well formed, so we used 
a pericardial tube, valved with a bioprosthesis, imilar to 
what Dr. Kreutzer discussed. It is of interest that a 
pericardial tube was the first conduit used for complete 
repair of a congenital heart defect. This was done by Dr. 
John Kirklin at the Mayo Clinic in 1964. That conduit has 
not necessitated reoperation i a follow-up of 29 years. 
Second, the point about the diameter of the conduit is 
important. One is able to tailor the diameter of our 
conduit by sizing the patch of pericardium over a dilator. 
One can therefore make the diameter any size that is 
desired. 
Dr. Charles A. Yaukah (Berlin, Germany). We have 
followed up 163 of 202 patients with aortic and pulmo- 
nary homograft valves in the right ventricular outflow 
tract (mostly pulmonary homografts) and examined the 
problems involved. We used the standard surgical 
method with a hood, usually polytetrafluoroethylene, at 
the proximal anastomotic site. We treated our patients 
with antiinflammatory drugs (aspirin), and I think this is 
an important issue, because we usually observe infiltra- 
tions of inflammatory cells in the viable valves. We 
studied a group of 40 children younger than age 2 years 
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to identify risk factors for early degeneration i this 
group of patients. It was interesting to see that the 
pulmonary homograft did better than the aortic ho- 
mograft in this younger age group. 
The pulmonary homograft showed 100% freedom from 
early calcification as compared with 19% for the aortic 
homograft at 20 months. Freedom from reoperation for 
the aortic and pulmonary homografts was 69% and 100% 
at 48 months, respectively. 
In summary, we are convinced that the pulmonary 
homograft will do better in the right ventricular outflow 
tract in children in conjunction with the use of antiinflam- 
matory drugs. 
Dr. Cerfolio. In the previously mentioned review by 
Bando and colleagues, there was an accelerated failure of 
the homografts in both positions, especially the aortic, in 
children younger than age 4 years. In some of the patients, 
homograft calcification was not present, but the tissues 
were contracted and edematous, and thrombus was seen 
in the retracted cusps. Some of these findings occurred 
within 2 years of implantation, and they had the appear- 
ance of an immunologic response. It will be interesting to
see whether aspirin will be effective in preventing such 
changes. 
Mr. Jaroslav F. Stark (London, England). We have 
used this excellent echnique in some special circum- 
stances. If one uses homograft or the first operation, one 
does not get the fibrous bed as the authors have shown for 
heterograft. Thus I would like to ask the authors, in view 
of their excellent experience, whether they modified their 
approach to insertion of the first homograft by using 
either homografts or heterografts in the Dacron tube and 
abandoning aortic and pulmonary homografts? 
Dr. Cerfolio. Mr. Stark has raised an interesting ques- 
tion. Should a Dacron tube, either valved or nonvalved, be 
used as the first conduit so that a good fibrous bed will be 
formed for an autologous tissue reconstruction when 
conduit replacement is required? It is true that our 
enthusiasm for cryopreserved homografts i waning. Per- 
haps a preliminary Dacron conduit subsequently replaced 
by an autologous tissue reconstruction will prove to have 
the greatest utility and longevity. Which conduit and in 
what order are questions that probably will be resolved 
only by further experience and follow-up. 
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